-
V4765-5MG
VALNOCTAMIDE (C005B-284503)
Price: $214.26List Price: $238.07Application Valnoctamide has been used: as a mood stabilizer to study its anti-cytomegalovirus (anti-CMV) effects in newborn mice brain as a hypnotic sedative to study its cytotoxic effects on oligodendrocyte precursor cells (OPCs) and human -
V4765-25MG
VALNOCTAMIDE (C005B-284504)
Price: $654.89List Price: $727.65Application Valnoctamide has been used: as a mood stabilizer to study its anti-cytomegalovirus (anti-CMV) effects in newborn mice brain as a hypnotic sedative to study its cytotoxic effects on oligodendrocyte precursor cells (OPCs) and human -
1708707-500MG
VALPROIC ACID
Price: $834.51List Price: $927.23This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the -
V0033000
VALPROIC ACID EUROPEAN PHARMACOPOEIA (EP) REFERENCE STANDARD (C005B-284736)
Price: $415.60List Price: $461.78General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the -
V408675-1ml
Valproic Acid (NSC 93819) sodium salt
Price: $222.56List Price: $247.29InformationValproic Acid (NSC 93819) sodium salt Valproic Acid sodium salt (NSC 93819, Sodium valproate) is a HDAC inhibitor by selectively inducing proteasomal degradation of HDAC2, used in the treatment of epilepsy, bipolar disorder and prevention -
13033-100
Valproic Acid (sodium salt)-100 g
Price: $479.70List Price: $533.00An analog of valeric acid, long used as an anticonvulsant inhibits Class I HDACs with an IC<sub>50</sub> of ~2 mM also inhibits GSK3 and depletes cellular IP3. -
13033-25
Valproic Acid (sodium salt)-25 g
Price: $192.86List Price: $214.29An analog of valeric acid, long used as an anticonvulsant inhibits Class I HDACs with an IC<sub>50</sub> of ~2 mM also inhibits GSK3 and depletes cellular IP3. -
Y0001422
VALPROIC ACID FOR SYSTEM SUITABILITY EUROPEAN PHARMACOPOEIA (EP) REFERENCE STANDARD
Price: $298.28List Price: $331.42General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the -
1708729-0.25ML
VALPROIC ACID RELATED COMPOUND A
Price: $2,481.52List Price: $2,757.24This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the -
1708718-50MG
VALPROIC ACID RELATED COMPOUND B
Price: $2,572.15List Price: $2,857.94This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the -
P4543-25G
VALPROIC ACID SODIUM SALT 98% (C005B-439285)
Price: $229.05List Price: $254.50Application Valproic acid sodium salt has been used: in resazurin viability assay to systematically study its effects of clinical doses on brain volume and offspring behavior to study its effect on atherosclerotic lesion size -
P4543-10G
VALPROIC ACID SODIUM SALT 98% (C005B-439286)
Price: $155.24List Price: $172.49Application Valproic acid sodium salt has been used: in resazurin viability assay to systematically study its effects of clinical doses on brain volume and offspring behavior to study its effect on atherosclerotic lesion size